Clinical Trial Update: Bariatric Dose-ranging Study With Dexmedetomidine [Phase 4]

View source ↗

Summary

A Phase 4 dose-ranging trial of dexmedetomidine in abdominal surgery patients was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Abdominal Surgery Patients
• Abdominal Surgery-related Complications

Drugs mentioned

• Dexmedetomidine (Dexmedetomidine)

Snippet

Sponsor: University of Texas Southwestern Medical Center | Conditions: Abdominal Surgery Patients | Phase 4 | Status: WITHDRAWN